• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环孢素 A 和桑福海林 A 增强顺铂在 C6 神经胶质瘤细胞中的化疗效果。

Cyclosporin A and sanglifehrin A enhance chemotherapeutic effect of cisplatin in C6 glioma cells.

机构信息

Department of Neurosurgery, The First Hospital of Jilin University, Changchun 130-021, PR China.

出版信息

Oncol Rep. 2010 Apr;23(4):1053-62. doi: 10.3892/or_00000732.

DOI:10.3892/or_00000732
PMID:20204291
Abstract

Glioma is the most common type of brain tumors in adults, and treatment of high-grade gliomas is still palliative. Studies to date have revealed only modest effect in attenuating growth of these tumors with single agent therapy, but combination treatment appears to be more effective. Cyclophilin A (CypA), a target of immunosuppressive drugs cyclosporin A (CsA) and sanglifehrin A (SFA), is an intracellular protein that has peptidyl-prolyl cis-trans isomerase (PPIase) enzymatic activity. Previously, we showed that overexpressed CypA induced chemoresistance in cancer cells. Here we provide evidence that combination of cisplatin with either CsA or SFA synergistically enhances apoptotic cell death in C6 glioma cells, compared with single agent treatment. Enhanced apoptotic cell death is a result of an increase in ROS generation and a decrease in intracellular glutathione levels. Consistently, CypA knockdown by siRNA also enhances cisplatin-induced apoptosis. Immunohistochemical analysis showed increased expression of CypA in human glioblastoma multiforme, but not in normal human astrocytes. CypA was also shown to be up-regulated in C6 glioma cells during hypoxia. In conclusion, CsA or SFA in combination with cisplatin synergistically enhances cisplatin-induced apoptosis in C6 glioma cells via inhibition of PPIase activity of CypA, indicating that development of new drugs that selectively inhibit the CypA PPIase activity without immune suppression may facilitate alleviation of chemoresistance in treatment of high-grade glioma.

摘要

神经胶质瘤是成年人中最常见的脑肿瘤类型,高级别神经胶质瘤的治疗仍然是姑息性的。迄今为止的研究表明,单一药物治疗只能轻微减缓这些肿瘤的生长,但联合治疗似乎更有效。亲环素 A(CypA)是免疫抑制剂环孢素 A(CsA)和桑利福林 A(SFA)的靶点,是一种细胞内蛋白,具有肽基脯氨酰顺反异构酶(PPIase)的酶活性。以前,我们表明过表达的 CypA 诱导癌细胞产生化疗耐药性。在这里,我们提供的证据表明,与单一药物治疗相比,顺铂与 CsA 或 SFA 的联合使用可协同增强 C6 神经胶质瘤细胞的细胞凋亡。增强的细胞凋亡是由于 ROS 生成增加和细胞内谷胱甘肽水平降低所致。一致地,siRNA 敲低 CypA 也增强了顺铂诱导的细胞凋亡。免疫组织化学分析显示 CypA 在人类多形性胶质母细胞瘤中表达增加,但在正常的人类星形胶质细胞中没有表达。在 C6 神经胶质瘤细胞缺氧期间也显示 CypA 上调。总之,CsA 或 SFA 与顺铂联合使用通过抑制 CypA 的 PPIase 活性协同增强顺铂诱导的 C6 神经胶质瘤细胞凋亡,表明开发选择性抑制 CypA PPIase 活性而不抑制免疫的新药可能有助于缓解高级别神经胶质瘤治疗中的化疗耐药性。

相似文献

1
Cyclosporin A and sanglifehrin A enhance chemotherapeutic effect of cisplatin in C6 glioma cells.环孢素 A 和桑福海林 A 增强顺铂在 C6 神经胶质瘤细胞中的化疗效果。
Oncol Rep. 2010 Apr;23(4):1053-62. doi: 10.3892/or_00000732.
2
Novel combinational treatment of cisplatin with cyclophilin A inhibitors in human heptocellular carcinomas.顺铂联合亲环素 A 抑制剂治疗人肝癌的新方法。
Arch Pharm Res. 2010 Sep;33(9):1401-9. doi: 10.1007/s12272-010-0914-x. Epub 2010 Oct 14.
3
Cyclophilin A as a target of Cisplatin chemosensitizers.亲环素 A 作为顺铂化疗增敏剂的作用靶点。
Curr Cancer Drug Targets. 2014;14(1):46-58. doi: 10.2174/15680096113136660109.
4
Transgenic mice overexpressing cyclophilin A are resistant to cyclosporin A-induced nephrotoxicity via peptidyl-prolyl cis-trans isomerase activity.过表达亲环素A的转基因小鼠通过肽基脯氨酰顺反异构酶活性对环孢素A诱导的肾毒性具有抗性。
Biochem Biophys Res Commun. 2004 Apr 16;316(4):1073-80. doi: 10.1016/j.bbrc.2004.02.160.
5
Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity.环孢素A通过诱导氧化应激和抑制亲环蛋白A的肽基脯氨酰顺反异构酶活性来阻断肌肉分化:亲环蛋白A可保护成肌细胞免受环孢素A诱导的细胞毒性。
FASEB J. 2002 Oct;16(12):1633-5. doi: 10.1096/fj.02-0060fje. Epub 2002 Aug 7.
6
Sanglifehrin A, a novel cyclophilin-binding compound showing immunosuppressive activity with a new mechanism of action.桑利夫林A,一种新型亲环素结合化合物,具有免疫抑制活性,作用机制新颖。
J Immunol. 2001 Jun 15;166(12):7165-71. doi: 10.4049/jimmunol.166.12.7165.
7
Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death.癌细胞中过表达的亲环素A可使细胞对缺氧和顺铂诱导的细胞死亡产生抗性。
Cancer Res. 2007 Apr 15;67(8):3654-62. doi: 10.1158/0008-5472.CAN-06-1759.
8
Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A.桑吉瑞辛A通过与亲环蛋白-D结合于不同于环孢素A的位点,从而作为线粒体通透性转换和心脏再灌注损伤的有效抑制剂。
J Biol Chem. 2002 Sep 20;277(38):34793-9. doi: 10.1074/jbc.M202191200. Epub 2002 Jul 2.
9
Cyclophilin A Maintains Glioma-Initiating Cell Stemness by Regulating Wnt/β-Catenin Signaling.亲环素 A 通过调控 Wnt/β-连环蛋白信号通路维持胶质瘤起始细胞干性。
Clin Cancer Res. 2017 Nov 1;23(21):6640-6649. doi: 10.1158/1078-0432.CCR-17-0774. Epub 2017 Aug 8.
10
Cyclosporine a induces growth arrest or programmed cell death of human glioma cells.环孢素A可诱导人胶质瘤细胞生长停滞或程序性细胞死亡。
Neurochem Int. 2005 Nov;47(6):430-41. doi: 10.1016/j.neuint.2005.05.010.

引用本文的文献

1
The potential role of cyclosporine A in cancer treatment: a comprehensive literature review.环孢素A在癌症治疗中的潜在作用:一项全面的文献综述。
Contemp Oncol (Pozn). 2024;28(4):271-282. doi: 10.5114/wo.2024.147009. Epub 2025 Jan 15.
2
Cyclophilin A: promising target in cancer therapy.亲环素 A:癌症治疗有前景的靶点。
Cancer Biol Ther. 2024 Dec 31;25(1):2425127. doi: 10.1080/15384047.2024.2425127. Epub 2024 Nov 8.
3
Molecular pathways in glioblastoma-derived stem cells to identify effective drug agents: A bioinformatics study.
胶质母细胞瘤衍生干细胞中用于识别有效药物的分子途径:一项生物信息学研究
J Family Med Prim Care. 2022 Jun;11(6):2856-2864. doi: 10.4103/jfmpc.jfmpc_1436_21. Epub 2022 Jun 30.
4
Downregulation of CyclophilinA/CD147 Axis Induces Cell Apoptosis and Inhibits Glioma Aggressiveness.下调亲环素 A/CD147 轴诱导细胞凋亡并抑制神经胶质瘤侵袭性。
Biomed Res Int. 2020 Jul 24;2020:7035847. doi: 10.1155/2020/7035847. eCollection 2020.
5
Predictive Value of Pin1 in Cervical Low-Grade Squamous Intraepithelial Lesions and Inhibition of Pin1 Exerts Potent Anticancer Activity against Human Cervical Cancer.Pin1在宫颈低度鳞状上皮内病变中的预测价值及Pin1的抑制对人宫颈癌具有强大的抗癌活性
Aging Dis. 2020 Feb 1;11(1):44-59. doi: 10.14336/AD.2019.0415. eCollection 2020 Feb.
6
Microglia are both a source and target of extracellular cyclophilin A.小胶质细胞既是细胞外亲环素A的来源,也是其作用靶点。
Heliyon. 2019 Sep 3;5(9):e02390. doi: 10.1016/j.heliyon.2019.e02390. eCollection 2019 Sep.
7
The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer.蛋白肽脯氨酰异构酶在脑癌中的多重作用。
Biomolecules. 2018 Oct 11;8(4):112. doi: 10.3390/biom8040112.
8
The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target.异构酶 PIN1 控制着众多致癌途径,是一个独特的药物靶点。
Nat Rev Cancer. 2016 Jul;16(7):463-78. doi: 10.1038/nrc.2016.49. Epub 2016 Jun 3.
9
Proline isomerisation as a novel regulatory mechanism for p38MAPK activation and functions.脯氨酸异构化作为p38丝裂原活化蛋白激酶激活和功能的一种新型调节机制。
Cell Death Differ. 2016 Oct;23(10):1592-601. doi: 10.1038/cdd.2016.45. Epub 2016 May 27.
10
CypA, a gene downstream of HIF-1α, promotes the development of PDAC.环孢素A(CypA)是缺氧诱导因子-1α(HIF-1α)下游的一个基因,可促进胰腺导管腺癌(PDAC)的发展。
PLoS One. 2014 Mar 24;9(3):e92824. doi: 10.1371/journal.pone.0092824. eCollection 2014.